Animal Model Systems to Evaluate the Antitumor Activity of Interferons

  • F. R. Balkwill
Part of the Developments in Medical Virology book series (DIMV, volume 4)


Interferons, IFNs, have complex regulatory actions on many cells of the body. It would be impossible to understand and optimise their anticancer activity solely from in vitro data or clinical experience in man. Experiments in animals can provide important information and have also been catalytic in promoting clinical trials.


Nude Mouse Human Tumor Xenograft Human IFNs Ovarian Cancer Xenograft Complex Regulatory Action 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Martin, D.S., Balis, M.E., Bernard-Fisher, B., Frei, E., Freireich, E.J., Heppner, G.H., Holland, J.F., Houghton, J.A., Houghton, P.J., Johnson, R.K., Mittelman, A. Cancer Res., 46, 2189–2192, 1986.PubMedGoogle Scholar
  2. 2.
    Giovanella, B.C., Fogh, J. Advances in Cancer Research, 44, 69–120, 1985.PubMedCrossRefGoogle Scholar
  3. 3.
    Giovanella, B.C., Stehlin, J.S., Shephard, R.C., Williams, L.J. Cancer, 52, 1146–1152, 1983.PubMedCrossRefGoogle Scholar
  4. 4.
    Balkwill, F.R. In: Interferon, vol.4: In vivo and clinical studies, (Eds. N.B. Finter and R.K. Oldham), Elsevier Science Publishers B.V., 1985.Google Scholar
  5. 5.
    Gresser, I., Belardelli, F., Maury, C, Tovey, M.G., Maunoury, M-T. Int.J.Cancer, 38, 251–257, 1986.PubMedCrossRefGoogle Scholar
  6. 6.
    Gresser, I., Belardelli, F., Maury, C, Manunoury, M-T., Tovey, M.G. J.Exp.Med., 158, 2095–2107, 1983.PubMedCrossRefGoogle Scholar
  7. 7.
    Freireich, E.J., Gehan, R.T., Rail, D.A., Schmidt, L.A., Skipper, H.E. Cancer Chemother.Rep., 50, 219–244, 1966.PubMedGoogle Scholar
  8. 8.
    Brunda, M., Rosenbaum, D., Stern, L. Int.J.Cancer, 34, 421–426, 1984.PubMedCrossRefGoogle Scholar
  9. 9.
    Ramani, P., Hart, I.R., Balkwill, F.R. Int.J.Cancer, 37, 563–568, 1986.PubMedCrossRefGoogle Scholar
  10. 10.
    Yamauoka, T., Takada, H., Yanagi, Y., Kataoka, T., Sakurai, Y. Cancer Chemother.Pharmacol., 14 184–187, 1985.Google Scholar
  11. 11.
    Brosjo, O., Bauer, H.C.F., Brostrom, L., Nilsonne, U., Nillsson, O.S., Reinholt, F.P., Strander, H., Tribukait, B. Cancer Res., 45, 5598–5602, 1985.PubMedGoogle Scholar
  12. 12.
    Hubbell, H.R., Kvaines-Krick, K., Carter, W.A., Strayer, D.R. Cancer Res., 45, 2481–2486, 1985.PubMedGoogle Scholar
  13. 13.
    Hofmann, V., Groscurth, P., Morant, R., Cserhati, M., Honegger, H.P., Von Hochstetter, A. Eur.J.Cancer Clin.Oncol., 21, 859–863, 1985.PubMedCrossRefGoogle Scholar
  14. 14.
    Twentyman, P.R., Workman, P., Wright, K.A., Bleehen, N.M. Br.J.Cancer, 52, 21–29, 1985.PubMedCrossRefGoogle Scholar
  15. 15.
    Balkwill, F.R., Goldstein, L., Stebbing, N. Int.J.Cancer, 613–617, 1985.Google Scholar
  16. 16.
    Balkwill, F.R., Stevens, M.H., Griffin, D.B., Thomas, J.A., Bodmer, J.G. Eur.J.Immunol., 1987 in press.Google Scholar
  17. 17.
    Carmichael, J., Fergusson, R.J., Wolf, CR., Balkwill, F.R., Smyth, J.F. Cancer Res., 46, 4916–4920, 1986.PubMedGoogle Scholar
  18. 18.
    Heston, W.O.W., Fleischmann, J., Tackett, R.E., Ratlift, T.L. Cancer Res., 44, 3220–3228, 1984.Google Scholar
  19. 19.
    Slater, L.M., Wetzel, M.W., Cescrio, T. Cancer, 48, 5–9, 1981.PubMedCrossRefGoogle Scholar
  20. 20.
    Marquet, R.L., Schellekens, H., Westbroek, D.L., Jeekel, J. Int. J.Cancer, 31, 223–226, 1983.PubMedCrossRefGoogle Scholar
  21. 21.
    Balkwill, F.R., Mowshowitz, S., Seilman, S.A., Moodie, E.M., Griffin, D.B., Fantes, K.H., Wolf, CR. Cancer Res., 44, 5355, 1984.Google Scholar
  22. 22.
    Fransen, L., Van der Heyden, J., Ruysschaert, R., Fiers, W. Eur.J.Cancer Clin.Oncol., 22, 419–426, 1986.PubMedCrossRefGoogle Scholar
  23. 23.
    Revel, M., Chebath, J. TIBS 11, 166–170, 1986.Google Scholar
  24. 24.
    Zoon, K.C, Karasaki, Y., Zur Nedden, D.L., Hu, R., Arnheiter, H. Proc.Natl.Acad.Sci., 83, 8226–8230, 1986.PubMedCrossRefGoogle Scholar
  25. 25.
    Wivel, N.A., Pitha, P.M. Int.J.Cancer, 30, 649–654, 1982.PubMedCrossRefGoogle Scholar
  26. 26.
    Gresser, I., Bourali-Maury, C P.S.E.B.R7, 144, 896–900, 1973.Google Scholar
  27. 27.
    Ramani, P., Hart, I.R., Balkwill, F.R. Int.TXancer, 37, 563–568, 1986.CrossRefGoogle Scholar
  28. 28.
    Gresser, I. Interferon, 6, 93–126, 1985.PubMedGoogle Scholar
  29. 29.
    Kataoka, T., Matsuura, N., Ohhashi, F., Suhara, Y. Cancer Res., 45, 3548–3553, 1985.PubMedGoogle Scholar
  30. 30.
    Uno, K., Shimizu, S., Ido, M., Naito, K., Inaba, K., Oku, T., Kishida, R., Muramatsu, S. Cancer Res., 45, 1320–1327, 1985.PubMedGoogle Scholar
  31. 31.
    Hanna, N. Biochimica et Biophysica Acta, 780, 213–226, 1985.PubMedGoogle Scholar
  32. 32.
    Balkwill, F.R., Proietti, E. Int.J.Cancer, 58, 375–380, 1986.CrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers, Boston 1988

Authors and Affiliations

  • F. R. Balkwill
    • 1
  1. 1.Biological Therapy LaboratoryImperial Cancer Research FundLondonUK

Personalised recommendations